Endocrine Flashcards
What are incretins?
Hormones produced by the GI tract which are secreted in response to a big meal and reduce blood glucose levels. They;
- Increase insulin secretion
- Inhibit glucagon production
- Slow glucose absorption by the GI tract
Main incretin = GLP-1
Which enzyme inhibits incretins?
DPP-4 (dipeptidyl peptidase - 4)
Metformin
MOA = increases insulin sensitivity + decreases hepatic gluconeogenesis
SE = GI upset / Lactic acidosis
Contraindications = eGFR < 30
Sitagliptin
Type = DPP-4 Inhibitor (Increases levels of GLP-1)
SE = GI upset / URTI symptoms / Headaches / Inc risk of pancreatitis
SLGT-2 Inhibitors
Dapagliflozin / empagliflozin
MOA = Inhibit SGT in the PCT which increases glucose excretion.
SE = Increased UTIs/Thrust / Fourniers gangrene / Can cause DKA!
Pros = causes weight loss
*NOTE - dapagliflozin is also licensed in the management of HF.
Liraglutide / Exanatide
GLP-1 Agonists
SC Injection + also licensed for weight loss
SE = Hypoglycemia!!! N&V / GI upset / Dizziness
May increase risk of pancreatitis
Piaglitazone
Thiazolidinedione
MOA = Activates PPAR-gamma receptors in adiopcytes which increases insulin sensitivity + decreases hepatic gluconeogenesis
SE = Fluid retention / HF / CKD / Anemia / Liver dysfunction / Inc risk of bone fractures / WEIGHT GAIN / can inc risk of bladder cancer
Sulfonylureas
Gliclazide
MOA = Inhibits K+ channels on beta cells leading to insulin secretion
SE = HYPOGLYCEMIA / weight gain / Hyponatremia / bone marrow toxicity
Contraindications: avoid post MI or Renal failure
Which diabetic agents cause weight gain
Pioglitazone + sulfonylureas (gliclazide)
Which diabetic agents can cause DKA
SGLT-2 inhibitors
Which diabetic agents are most likely to cause Hypoglycemia
GLP-1 Agonists
Sulfonylureas
Which diabetic agents can aid weight loss
GLP 1 agonists + SLGT-2 inhibitors
Central diabetes insipidus
Decreased secretion of ADH from posterior pituitary
Causes = Idiopathic or secondary to pituitary surgery, head injury, haemochromatosis, CNS infection, Craniopharyngiomas .
Nephrogenic diabetes insipidus
A failure of the Collecting ducts to respond to ADH
Causes = tubulo-interstitial nephritis / Lithium therapy / avpr2 mutation / hypercalcemia / hypokalemia / Sjogren’s syndrome
Which cancer is hashimoto’s thyroiditis associated with?
MALT lymphoma
Hashimoto’s thyroiditis autoantibodies
Anti-TPO + Anti-thyroglobulin (Anti-Tg)
Which drug most commonly exacerbates hyperthyroidism
Amiodarone
Functions of cortisol
Increases alertness
Increases blood glucose
Increases metabolism
Inhibits the immune system
Inhibits bone formation
ABG/VBG findings in Cushing’s disease
Hypokalemic metabolic alkalosis + Hypernatremia
Blood findings in Addison’s disease
Hyponatremia + Hyperkalemia
Management of acromegaly in a patient who cannot undergo surgery
GH antagonists (pegvisomant)
Somatostatin analogue (Ocreotide) - inhibit GH release
Dopamine agonists (Bromocriptine)
Advice for pregnant women with hypothyroidism
Increase levothyroxine dose by 50%
Digoxin causes gynaecomastia, true or false?
MEN type 1
Parathyroid
Pituitary
Pancreas
+ Adrenal + Thyroid
Often presents as hypercalcemia (hyperparathyroidism) or recurrent hypoglycemia (insulinoma) or recurrent gastric ulcers (gastrinoma)
Mutation = MEN1 gene
MEN type 2
Parathyroid
Phaeochromocytoma
Medullary thyroid cancer
RET oncogene mutation
MEN type 3
Medullary thyroid cancer
Pheochromocytoma
Marfinoid
Neuromas
Main side effects of carbimazole
Agranulocytosis (infections)
Acute pancreatitis
Visual field defects seen in prolactinoma’s
Bitemporal hemianopia
Bitemporal superior quandrantopia
Hashimoto’s thyroiditis antibodies
Anti-TPO
Grave’s disease antibodies
TSH antibodies
First line treatment for cerebral mets
Dexamethasone